In vitro miconazole susceptibility and clinical outcome in vulvovaginal candidiasis

International Journal of Gynecology and Obstetrics

Volumn 97, Issue 3, 2007, Pages 207-208

  Fan, S R ^a   Liu, X P ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Miconazole; Susceptibility; Treatment; Vulvovaginal candidiasis

Indexed keywords

MICONAZOLE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG SENSITIVITY; FEMALE; FUNGUS CULTURE; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; VAGINA CANDIDIASIS;

EID: 34248342551     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.03.017     Document Type: Article

References (4)

1. Rex J.H., Pfaller M.A., Galgiani J.N., Bartlett M.S., Espinel-Ingroff A., Ghannoum M.A., et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin Infect Dis 24 (1997) 235-247
2. Sobel J.D., Zervos M., Reed B.D., Hooton T., Soper D., Nyirjesy P., et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 47 (2003) 34-38
3. Costa M., Passos X.S., Miranda A.T., de Araujo R.S., Paula C.R., and Silva Mdo R. Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia 157 (2004) 43-47
4. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 178 (1998) 203-211